title: Acute adverse reaction to hylan G-F 20: comment on the article by Martens.
authors.forename: J
authors.initials: J
authors.lastname: Tomás Gil
authors.forename: P
authors.initials: P
authors.lastname: Lopez Mateu
authors.forename: J
authors.initials: J
authors.lastname: Alegre
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D006820:Hyaluronic Acid / Q000008:administration & dosage / Q000009:adverse effects*; D007270:Injections, Intra-Articular; D007719:Knee Joint / Q000187:drug effects / Q000473:pathology; D020370:Osteoarthritis, Knee / Q000150:complications / Q000188:drug therapy / Q000473:pathology; D010146:Pain / Q000188:drug therapy / Q000209:etiology; D013582:Synovial Fluid / Q000166:cytology; D013585:Synovitis / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D018501:Antirheumatic Agents; D006820:Hyaluronic Acid